A dark and stormy look at biological markers in the blood that can lead to earlier Alzheimer’s diagnosis and treatment. Researchers hope circulating biomarkers will enable earlier detection and better monitoring of the neurodegenerative disorder—and perhaps help usher in new treatments. The illustration features neurons, cerebral blood vessels, tau proteins, and amyloid plaques.